These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 30997816

  • 1. The Effect of Hormonal Contraception on Cervicovaginal Mucosal End Points Associated with HIV Acquisition.
    Thurman A, Chandra N, Schwartz JL, Brache V, Chen BA, Asin S, Rollenhagen C, Herold BC, Fichorova RN, Hillier SL, Weiner DH, Mauck C, Doncel GF.
    AIDS Res Hum Retroviruses; 2019 Sep; 35(9):853-864. PubMed ID: 30997816
    [Abstract] [Full Text] [Related]

  • 2. Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.
    Zalenskaya IA, Chandra N, Yousefieh N, Fang X, Adedipe OE, Jackson SS, Anderson SM, Mauck CK, Schwartz JL, Thurman AR, Doncel GF.
    J Clin Invest; 2018 Oct 01; 128(10):4622-4638. PubMed ID: 30222141
    [Abstract] [Full Text] [Related]

  • 3. Effect of Hormonal Contraception on Pharmacokinetics of Vaginal Tenofovir in Healthy Women: Increased Tenofovir Diphosphate in Injectable Depot Medroxyprogesterone Acetate Users.
    Thurman AR, Schwartz JL, Brache V, Chen BA, Chandra N, Kashuba ADM, Weiner DH, Mauck C, Doncel GF.
    J Acquir Immune Defic Syndr; 2019 Jan 01; 80(1):79-88. PubMed ID: 30212395
    [Abstract] [Full Text] [Related]

  • 4. Increased Cervical CD4+CCR5+ T Cells Among Kenyan Sex Working Women Using Depot Medroxyprogesterone Acetate.
    Lajoie J, Tjernlund A, Omollo K, Edfeldt G, Röhl M, Boily-Larouche G, Cheruiyot J, Kimani M, Kimani J, Oyugi J, Broliden K, Fowke KR.
    AIDS Res Hum Retroviruses; 2019 Mar 01; 35(3):236-246. PubMed ID: 30585733
    [Abstract] [Full Text] [Related]

  • 5. Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected Women.
    Guthrie BL, Introini A, Roxby AC, Choi RY, Bosire R, Lohman-Payne B, Hirbod T, Farquhar C, Broliden K.
    J Acquir Immune Defic Syndr; 2015 May 01; 69(1):1-10. PubMed ID: 25622059
    [Abstract] [Full Text] [Related]

  • 6. Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi.
    Haddad LB, Tang JH, Davis NL, Kourtis AP, Chinula L, Msika A, Tegha G, Hosseinipour MC, Nelson JAE, Hobbs MM, Gajer P, Ravel J, De Paris K.
    mSphere; 2023 Feb 21; 8(1):e0058522. PubMed ID: 36622252
    [Abstract] [Full Text] [Related]

  • 7. Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues.
    Chandra N, Thurman AR, Anderson S, Cunningham TD, Yousefieh N, Mauck C, Doncel GF.
    AIDS Res Hum Retroviruses; 2013 Mar 21; 29(3):592-601. PubMed ID: 23189932
    [Abstract] [Full Text] [Related]

  • 8. Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells.
    Mitchell CM, McLemore L, Westerberg K, Astronomo R, Smythe K, Gardella C, Mack M, Magaret A, Patton D, Agnew K, McElrath MJ, Hladik F, Eschenbach D.
    J Infect Dis; 2014 Aug 15; 210(4):651-5. PubMed ID: 24652495
    [Abstract] [Full Text] [Related]

  • 9. Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques.
    Bosinger SE, Tharp GK, Patel NB, Zhao C, Payne TL, Dietz Ostergaard S, Butler K, Ellis S, Johnson RL, Kersh EN, McNicholl JM, Vishwanathan SA.
    Am J Reprod Immunol; 2018 Oct 15; 80(4):e13029. PubMed ID: 30076667
    [Abstract] [Full Text] [Related]

  • 10. The effect of menopause on the innate antiviral activity of cervicovaginal lavage.
    Chappell CA, Isaacs CE, Xu W, Meyn LA, Uranker K, Dezzutti CS, Moncla BJ, Hillier SL.
    Am J Obstet Gynecol; 2015 Aug 15; 213(2):204.e1-6. PubMed ID: 25818668
    [Abstract] [Full Text] [Related]

  • 11. Human vaginal histology in long-term users of the injectable contraceptive depot-medroxyprogesterone acetate.
    Bahamondes MV, Castro S, Marchi NM, Marcovici M, Andrade LA, Fernandes A, Bahamondes L.
    Contraception; 2014 Aug 15; 90(2):117-22. PubMed ID: 24613369
    [Abstract] [Full Text] [Related]

  • 12. Effect of progestin-based contraceptives on HIV-associated vaginal immune biomarkers and microbiome in adolescent girls.
    Nasr MA, Aldous A, Daniels J, Joy C, Capozzi E, Yang M, Moriarty P, Emmanuel-Baker V, Malcolm S, Green SJ, Gomez-Lobo V, Ghosh M.
    PLoS One; 2024 Aug 15; 19(7):e0306237. PubMed ID: 39008499
    [Abstract] [Full Text] [Related]

  • 13. Comparison of Mucosal Markers of Human Immunodeficiency Virus Susceptibility in Healthy Premenopausal Versus Postmenopausal Women.
    Thurman AR, Yousefieh N, Chandra N, Kimble T, Asin S, Rollenhagen C, Anderson SM, Herold BC, Freiermuth JL, Starkman BS, Mesquita PMM, Richardson-Harman N, Cunningham T, Hillier S, Rabe L, Schwartz JL, Doncel GF.
    AIDS Res Hum Retroviruses; 2017 Aug 15; 33(8):807-819. PubMed ID: 28398069
    [Abstract] [Full Text] [Related]

  • 14. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
    Mostad SB, Overbaugh J, DeVange DM, Welch MJ, Chohan B, Mandaliya K, Nyange P, Martin HL, Ndinya-Achola J, Bwayo JJ, Kreiss JK.
    Lancet; 1997 Sep 27; 350(9082):922-7. PubMed ID: 9314871
    [Abstract] [Full Text] [Related]

  • 15. The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.
    Fichorova RN, Chen PL, Morrison CS, Doncel GF, Mendonca K, Kwok C, Chipato T, Salata R, Mauck C.
    mBio; 2015 Sep 01; 6(5):e00221-15. PubMed ID: 26330510
    [Abstract] [Full Text] [Related]

  • 16. Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis.
    Dabee S, Tanko RF, Brown BP, Bunjun R, Balle C, Feng C, Konstantinus IN, Jaumdally SZ, Onono M, Nair G, Palanee-Phillips T, Gill K, Baeten JM, Bekker LG, Passmore JS, Heffron R, Jaspan HB, Happel AU.
    Front Immunol; 2021 Sep 01; 12():760504. PubMed ID: 34956191
    [Abstract] [Full Text] [Related]

  • 17. A Longitudinal Assessment of Cervical Inflammation and Immunity Associated with HIV-1 Infection, Hormonal Contraception, and Pregnancy.
    Morrison CS, Fichorova R, Chen PL, Kwok C, Deese J, Yamamoto H, Anderson S, Chipato T, Salata R, Doncel GF.
    AIDS Res Hum Retroviruses; 2018 Oct 01; 34(10):889-899. PubMed ID: 30047279
    [Abstract] [Full Text] [Related]

  • 18. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch?
    Thurman AR, Hammond N, Brown HE, Roddy ME.
    J Pediatr Adolesc Gynecol; 2007 Apr 01; 20(2):61-5. PubMed ID: 17418388
    [Abstract] [Full Text] [Related]

  • 19. Depot medroxyprogesterone acetate (DMPA) enhances susceptibility and increases the window of vulnerability to HIV-1 in humanized mice.
    Wessels JM, Nguyen PV, Vitali D, Mueller K, Vahedi F, Felker AM, Dupont HA, Bagri P, Verschoor CP, Deshiere A, Mazzulli T, Tremblay MJ, Ashkar AA, Kaushic C.
    Sci Rep; 2021 Feb 16; 11(1):3894. PubMed ID: 33594113
    [Abstract] [Full Text] [Related]

  • 20. Genital Injury Signatures and Microbiome Alterations Associated With Depot Medroxyprogesterone Acetate Usage and Intravaginal Drying Practices.
    Birse KD, Romas LM, Guthrie BL, Nilsson P, Bosire R, Kiarie J, Farquhar C, Broliden K, Burgener AD.
    J Infect Dis; 2017 Feb 15; 215(4):590-598. PubMed ID: 28011908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.